Journals / Kulak Burun Boğaz ve Baş Boyun Cerrahisi / 2020 / Cilt: 28 - Sayı: 2

COVID-19 and Anosmia

COVID-19 ve Anosmi

Pages
S61–S63
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

With this short review, we aim to explain the mechanism of the occurrence of COVID-19 infection-related anosmia with current data.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Symptoms of the 2019-2020 new coronavirus pandemic (COVID-19) that affect the whole world typically include dry cough, fever and shortness of breath.
📊
Key Findings & Data:Besides these symptoms, high rates of sudden onset olfactory disorders in the data from the regions where the disease is observed suggest that this disease is related to the pandemic.
💡
Conclusion & Impact:With this short review, we aim to explain the mechanism of the occurrence of COVID-19 infection-related anosmia with current data.
🔬Design:Review & Systematic Survey
📍Scope:2019-2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Symptoms of the 2019-2020 new coronavirus pandemic (COVID-19) that affect the whole world typically include dry cough, fever and shortness of breath. Besides these symptoms, high rates of sudden onset olfactory disorders in the data from the regions where the disease is observed suggest that this disease is related to the pandemic. The situation that arises as the data are collected; the first sign of COVID-19 disease in about 5% is sudden onset anosmia. Although there are studies in the literature that try to explain the mechanisms of smell disorder after viral infection with many viral infection agents, there is no specific study on COVID-19. However, ACE2 receptor and TMPRSS2 proteins, which are key in the entry of this virus into the cell, may also play a role in the development of anosmia. With this short review, we aim to explain the mechanism of the occurrence of COVID-19 infection-related anosmia with current data.

Özet

Tüm dünyayı etkisi altına alan 2019-2020 yeni koronavirüs pandemisi (COVID-19) belirtileri tipik olarak kuru öksürük, ateş ve nefesdarlığını içerir. Bu belirtilerin yanında, pandemi başlangıcından itibaren, hastalığın yoğun görüldüğü bölgelerden gelen verilerde ani başlangıçlı koku alma bozuklarının yüksek oranlarda raporlanması buhastalığın pandemi ile ilişkili olduğunu düşündürmektedir. Veriler toplandıkça ortaya çıkan duruma göre yaklaşık %5 oranında COVID-19hastalığının ilk belirtisi ani başlayan anosmidir. Bir çok viral enfeksiyon etkeni ile yapılmış viral enfeksiyon sonrası koku alma bozukluğumekanizmalarını açıklamaya çalışan literatürde çalışmalar olmasınarağmen COVID-19 ile ilgili spesifik çalışma yoktur. Ancak, bu virüsünhücre içine girişinde anahtar önemi olan ACE2 reseptör ve TMPRSS2proteinleri anosmi gelişmesinde de rol alabilir. Bu kısa derleme ile bizde güncel veriler eşliğinde COVID-19 enfeksiyonu ilişkili anosmininortaya çıkış mekanizmasını anlatmayı amaçlamaktayız.

🔖

Cite This Article

ÇETİNKAYA, E. A., SELÇUK, Ö. T., EYİGÖR, H., GÜR, Ö. E. (2020). COVID-19 and Anosmia. Kulak Burun Boğaz ve Baş Boyun Cerrahisi, Cilt: 28 - Sayı: 2, S61–S63. https://ajindex.com/articles/346864

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. World Health Organization (WHO). Coronavirus disease (COVID-19) Pandemic study. Accessed on Apr 1, 2020. [Link] 2. American Academy of Otolaryngology-Head and Neck Surgery. COVID-19 anosmia reporting tool for clinicians. Accessed on March 27, 2020. [Link] 3. Yamagishi M, Fujiwara M, Nakamura H. Olfactory mucosal findings and clinical course in patients with olfactory disorders following upper respiratory viral infection. Rhinology. 1994
  2. 32(3):113-8. [PubMed] 4. Suzuki M, Saito K, Min WP, Vladau C, Toida K, Itoh H, et al. Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope. 2007
  3. 117(2):272-7. [Crossref] [PubMed] [PMC] 5. Hummel T, Whitcroft KL, Andrews P, Altundag A, Cinghi C, Costanzo RM, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017
  4. 54(26):1-30. [Crossref] [PubMed] 6. Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. Accessed on Apr 1, 2020. [Crossref] [Link] 7. Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004
  5. 203(2):631-7. [Crossref] [PubMed] [PMC] 8. Brann DH, Tsukahara T, Weinreb C, Logan DW, Datta SR. Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patient. p.25. Accessed on March 26, 2020. [Link] 9. Bertram S, Heurich A, Lavender H, Gierer S, Danish S, Perin P, et al. Influenza and SARScoronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS One. 2012
  6. 7(4):e35876. [Crossref] [PubMed] [PMC] 10. Bagheri SHR, Asghari AM, Farhadi M, Shamshiri AR, Kabir A, Kamvara SK, et al. Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak. Accessed on March 26, 2020. [Crossref] [Link]